• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative.阿尔茨海默病神经影像学倡议中人为的轻度认知障碍低至正常逆转率。
Alzheimers Dement. 2019 Apr;15(4):561-569. doi: 10.1016/j.jalz.2018.10.008. Epub 2019 Jan 11.
2
MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative.使用阿尔茨海默病神经影像学倡议中的神经心理学标准,使 MCI 恢复正常。
Alzheimers Dement. 2019 Oct;15(10):1322-1332. doi: 10.1016/j.jalz.2019.06.4948. Epub 2019 Sep 5.
3
Is there an MCI reversion to cognitively normal? Analysis of Alzheimer's disease biomarkers profiles.是否存在从轻度认知障碍(MCI)向认知正常的逆转?对阿尔茨海默病生物标志物谱的分析。
Int Psychogeriatr. 2015 Mar;27(3):429-37. doi: 10.1017/S1041610214002129. Epub 2014 Sep 26.
4
Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.轻度认知障碍的神经心理学标准提高了诊断准确性、生物标志物关联性和进展率。
J Alzheimers Dis. 2014;42(1):275-89. doi: 10.3233/JAD-140276.
5
Early versus late MCI: Improved MCI staging using a neuropsychological approach.早期与晚期 MCI:使用神经心理学方法改善 MCI 分期。
Alzheimers Dement. 2019 May;15(5):699-708. doi: 10.1016/j.jalz.2018.12.009. Epub 2019 Feb 6.
6
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.两种言语记忆测量方法联合应用对阿尔茨海默病所致轻度认知障碍的诊断及预后价值
J Alzheimers Dis. 2017;58(3):909-918. doi: 10.3233/JAD-170073.
7
Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis.轻度认知障碍中基于统计得出的亚型及其与脑脊液和基因生物标志物的关联:一项潜在类别分析
J Int Neuropsychol Soc. 2017 Aug;23(7):564-576. doi: 10.1017/S135561771700039X. Epub 2017 Jun 5.
8
The Transition of Mild Cognitive Impairment Over Time: An AV45- and FDG-PET Study of Reversion and Conversion Phenomena.随时间推移的轻度认知障碍的转变:AV45 和 FDG-PET 研究中的逆转和转化现象。
Curr Alzheimer Res. 2021;18(9):721-731. doi: 10.2174/1567205018666211124110710.
9
Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.轻度认知障碍和轻度阿尔茨海默病中阿尔茨海默病评估量表-认知子量表变体:随时间的变化及强化策略的影响
Alzheimers Res Ther. 2016 Feb 12;8:8. doi: 10.1186/s13195-016-0170-5.
10
Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.循环饱和长链脂肪酸与阿尔茨海默病神经影像学倡议 (ADNI) 队列中轻度认知障碍和阿尔茨海默病风险的关联。
EBioMedicine. 2023 Nov;97:104818. doi: 10.1016/j.ebiom.2023.104818. Epub 2023 Oct 2.

引用本文的文献

1
Detecting label noise in longitudinal Alzheimer's data with explainable artificial intelligence.使用可解释人工智能检测纵向阿尔茨海默病数据中的标签噪声。
Brain Inform. 2025 Jun 10;12(1):15. doi: 10.1186/s40708-025-00261-2.
2
Characterizing bidirectional transitions in mild cognitive impairment and post-reversion based on longitudinal neuroimaging and cognitive assessments.基于纵向神经影像学和认知评估对轻度认知障碍及恢复后的双向转变进行特征描述。
Alzheimers Dement. 2025 May;21(5):e70263. doi: 10.1002/alz.70263.
3
Plasma proteomic characterization of motoric cognitive risk and mild cognitive impairment.运动性认知风险和轻度认知障碍的血浆蛋白质组学特征
Alzheimers Dement. 2025 Feb;21(2):e14429. doi: 10.1002/alz.14429. Epub 2025 Jan 30.
4
Association of Favorable Cerebrospinal Fluid Markers With Reversion of Mild Cognitive Impairment Due to Parkinson's Disease.脑脊液有利标志物与帕金森病所致轻度认知障碍逆转的关联
J Neuropsychiatry Clin Neurosci. 2025 Spring;37(2):131-136. doi: 10.1176/appi.neuropsych.20240099. Epub 2025 Jan 10.
5
Polygenic Score for Conscientiousness Is a Protective Factor for Reversion from Mild Cognitive Impairment to Normal Cognition.尽责性多基因评分是从轻度认知障碍恢复为正常认知的保护因素。
Adv Sci (Weinh). 2024 Aug;11(29):e2309889. doi: 10.1002/advs.202309889. Epub 2024 Jun 5.
6
Associations of cerebrospinal fluid complement proteins with Alzheimer's pathology, cognition, and brain structure in non-dementia elderly.脑脊液补体蛋白与非痴呆老年人阿尔茨海默病病理、认知和大脑结构的关联。
Alzheimers Res Ther. 2024 Jan 18;16(1):12. doi: 10.1186/s13195-023-01377-5.
7
Predictors and outcomes of fluctuations in the clinical dementia rating scale.临床痴呆评定量表波动的预测因素和结果。
Alzheimers Dement. 2024 Mar;20(3):2080-2088. doi: 10.1002/alz.13679. Epub 2024 Jan 15.
8
Exploring the Impact of Age of Onset of Mild Cognitive Impairment on the Profile of Cognitive and Psychiatric Symptoms.探索轻度认知障碍发病年龄对认知和精神症状特征的影响。
Geriatrics (Basel). 2023 Sep 25;8(5):96. doi: 10.3390/geriatrics8050096.
9
Cerebral blood flow, tau imaging, and memory associations in cognitively unimpaired older adults.认知未受损的老年人的脑血流量、tau蛋白成像与记忆关联
Cereb Circ Cogn Behav. 2022 Oct 27;3:100153. doi: 10.1016/j.cccb.2022.100153. eCollection 2022.
10
Association of rs2072446 in the NGFR gene with the risk of Alzheimer's disease and amyloid-β deposition in the brain.NGFR 基因 rs2072446 多态性与阿尔茨海默病发病风险及脑内淀粉样-β沉积的关联
CNS Neurosci Ther. 2022 Dec;28(12):2218-2229. doi: 10.1111/cns.13965. Epub 2022 Sep 8.

本文引用的文献

1
Derivation of cutoffs for the Elecsys amyloid β (1-42) assay in Alzheimer's disease.阿尔茨海默病中Elecsysβ淀粉样蛋白(1-42)检测临界值的推导
Alzheimers Dement (Amst). 2018 Aug 11;10:698-705. doi: 10.1016/j.dadm.2018.07.002. eCollection 2018.
2
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.阿尔茨海默病的脑脊液生物标志物与淀粉样蛋白-β PET 一致,并可预测临床进展:在 BioFINDER 和 ADNI 队列中使用全自动免疫分析的研究。
Alzheimers Dement. 2018 Nov;14(11):1470-1481. doi: 10.1016/j.jalz.2018.01.010. Epub 2018 Mar 1.
3
Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study.通过心理测量学精确识别轻度认知障碍揭示多奈哌齐的益处:ADCS维生素E和多奈哌齐治疗轻度认知障碍研究的二次分析
Alzheimers Dement (N Y). 2017 Dec 1;4:11-18. doi: 10.1016/j.trci.2017.11.001. eCollection 2018.
4
Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis.轻度认知障碍中基于统计得出的亚型及其与脑脊液和基因生物标志物的关联:一项潜在类别分析
J Int Neuropsychol Soc. 2017 Aug;23(7):564-576. doi: 10.1017/S135561771700039X. Epub 2017 Jun 5.
5
Effects of MCI subtype and reversion on progression to dementia in a community sample.社区样本中轻度认知障碍亚型及逆转对痴呆进展的影响。
Neurology. 2017 Jun 6;88(23):2225-2232. doi: 10.1212/WNL.0000000000004015. Epub 2017 May 10.
6
Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment.经验性定义的轻度认知障碍亚型中由 informant 报告的日常功能的纵向轨迹。
J Int Neuropsychol Soc. 2017 Jul;23(6):521-527. doi: 10.1017/S1355617717000285. Epub 2017 May 10.
7
Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria.轻度认知障碍中异质性皮质萎缩模式未被传统诊断标准所捕捉。
Neurology. 2016 Nov 15;87(20):2108-2116. doi: 10.1212/WNL.0000000000003326. Epub 2016 Oct 19.
8
Does mild cognitive impairment always lead to dementia? A review.轻度认知障碍是否总会导致痴呆?一篇综述。
J Neurol Sci. 2016 Oct 15;369:57-62. doi: 10.1016/j.jns.2016.07.055. Epub 2016 Jul 26.
9
Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition: A Systematic Review of Literature and Meta-Analysis.轻度认知障碍自发恢复至正常认知:文献系统综述与荟萃分析
J Am Med Dir Assoc. 2016 Oct 1;17(10):943-8. doi: 10.1016/j.jamda.2016.06.020. Epub 2016 Aug 5.
10
Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials.连续认知评估产生的练习效应:对临床前阿尔茨海默病随机对照试验的影响。
Alzheimers Dement (Amst). 2015 Mar 29;1(1):103-11. doi: 10.1016/j.dadm.2014.11.003. eCollection 2015 Mar.

阿尔茨海默病神经影像学倡议中人为的轻度认知障碍低至正常逆转率。

Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative.

机构信息

Veterans Affairs San Diego Healthcare System, San Diego, CA, USA; Department of Psychiatry, University of California, San Diego, School of Medicine, La Jolla, CA, USA.

San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.

出版信息

Alzheimers Dement. 2019 Apr;15(4):561-569. doi: 10.1016/j.jalz.2018.10.008. Epub 2019 Jan 11.

DOI:10.1016/j.jalz.2018.10.008
PMID:30610833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6461519/
Abstract

INTRODUCTION

We examined reasons for low mild cognitive impairment (MCI)-to-cognitively normal (CN) reversion rates in the Alzheimer's Disease Neuroimaging Initiative (ADNI).

METHODS

CN and MCI participants were identified as remaining stable, progressing, or reverting at 1-year of follow-up (Year 1). Application of ADNI's MCI criteria at Year 1 in addition to Alzheimer's disease biomarkers by group were examined.

RESULTS

The MCI-to-CN reversion rate was 3.0%. When specific components were examined, 22.5% of stable MCI participants had normal memory performance at Year 1 and their Alzheimer's disease biomarkers were consistent with the stable CN group. At Year 1, when all MCI criteria were not met, the more subjective Clinical Dementia Rating rather than objective memory measure appeared to drive continuation of the MCI diagnosis.

DISCUSSION

Results demonstrate an artificially low 1-year MCI-to-CN reversion rate in ADNI-diagnosed participants. If the Logical Memory cutoffs had been consistently applied, the reversion rate would have been at least 21.8%.

摘要

简介

我们研究了阿尔茨海默病神经影像学倡议(ADNI)中轻度认知障碍(MCI)到认知正常(CN)逆转率低的原因。

方法

在 1 年随访(第 1 年)时,将 CN 和 MCI 参与者确定为稳定、进展或逆转。检查第 1 年时 ADNI 的 MCI 标准的应用,以及按组的阿尔茨海默病生物标志物。

结果

MCI 到 CN 的逆转率为 3.0%。当检查特定的组成部分时,22.5%的稳定 MCI 参与者在第 1 年的记忆表现正常,他们的阿尔茨海默病生物标志物与稳定的 CN 组一致。在第 1 年,当不符合所有 MCI 标准时,更主观的临床痴呆评定量表而不是客观的记忆测量似乎推动了 MCI 诊断的继续。

讨论

结果表明,ADNI 诊断的参与者中 1 年 MCI 到 CN 的逆转率人为偏低。如果逻辑记忆的截止值一直被应用,那么逆转率至少会是 21.8%。